AMN Healthcare AMN Effective Income Tax Rate Reconciliation Tax Credits Research

Effective Income Tax Rate Reconciliation Tax Credits Research at other companies

Avanos MedicalAVNS

-2.3%-3.2pp

Option Care Health, Inc.OPCH

——

Other financials

Income statement

See full

Revenue$1.4B+99.9%

Gross profit$368.8M+86.2%

Operating income$117.2M+837%

Net income$62.2M+5,793%

EPS (diluted)$1.59+5,400%

Balance sheet

See full

Cash & equivalents$595.0M+528%

Total debt$776.9M-12.4%

Total equity$712.8M-0.3%

Total assets$2.6B+8.7%

Cash flow

See full

Operating cash flow$562.5M+507%

CapEx$7.2M-27.4%

Free cash flow$555.2M+571%

Valuation

See full

Market cap$1.23B+49.8%

Enterprise value$1.41B-11.9%

P/S0.4×+0.1×

Profitability

See full

Gross margin27.6%-2.5pp

Operating margin-9.8%-14.2pp

Net margin-0.9%-0.4pp

FCF margin20.7%+11.6pp

Returns & leverage

See full

Return on equity-4.5%-2.0pp

Debt / equity1.1×-0.2×

Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch.

The official record: AMN Healthcare’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's effective income tax rate reconciliation tax credits research.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AMN Healthcare's effective income tax rate reconciliation tax credits research?: AMN Healthcare (AMN) reported effective income tax rate reconciliation tax credits research of 0.9% in Q4 2025.
What does effective income tax rate reconciliation tax credits research mean?: This metric tracks the total value of research-related tax credits applied to reduce the company's overall tax liability. It serves as an indicator of the company's investment in R&D and its ability to utilize tax-advantaged programs.